APA Alıntı

Liu, P., Zhao, L., Loos, F., Iribarren, K., Kepp, O., & Kroemer, G. (2018). Epigenetic anticancer agents cause HMGB1 release in vivo. Oncoimmunology.

Chicago Stili Alıntı

Liu, Peng, Liwei Zhao, Friedemann Loos, Kristina Iribarren, Oliver Kepp, ve Guido Kroemer. "Epigenetic Anticancer Agents Cause HMGB1 Release in Vivo." Oncoimmunology 2018.

MLA Alıntı

Liu, Peng, et al. "Epigenetic Anticancer Agents Cause HMGB1 Release in Vivo." Oncoimmunology 2018.